{"id":115059,"date":"2026-09-01T12:15:14","date_gmt":"2026-09-01T12:15:14","guid":{"rendered":"https:\/\/www.europesays.com\/britain\/115059\/"},"modified":"2026-09-01T12:15:14","modified_gmt":"2026-09-01T12:15:14","slug":"merck-kgaa-shares-rise-1-7-after-hsbc-upgrades-stock-to-buy","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/britain\/115059\/","title":{"rendered":"Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy"},"content":{"rendered":"<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/558f89ce4ef8a7444e1f7bea34bd45738fcab029380b19efc02e0c7983e08495\/lightyear_networkapi\/resizefit_w960%3Bquality_80%3Bformat_webp\/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finvestorshub_458%2F2428398e8c0310bf6172997a7d56acea.png\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Woman in mask and gown holding a test tube \u00a9Adobe Stock Images\" height=\"527\" width=\"960\" class=\"yf-1f8hkhu loader\"\/><\/a> Woman in mask and gown holding a test tube \u00a9Adobe Stock Images           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Merck KGaA (NYSE:MRK) shares rose 1.7% to \u20ac141.30 after HSBC upgraded its rating on the Darmstadt-based science and technology group to &#8220;Buy&#8221; from &#8220;Hold&#8221;.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">HSBC also named Merck KGaA among its preferred companies in the life sciences tools sector, alongside Lonza, Danaher and Agilent.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Analysts cited the company&#8217;s valuation, first-half 2026 growth and its performance relative to the recent broader sector rally among the reasons for the upgrade.  <\/p>\n<p>            Second-quarter organic sales growth accelerates          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Merck KGaA reported second-quarter 2026 results in early August, with organic sales growth increasing to 4.1% from 2.9% during the first quarter.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Within the business, Life Science Process Solutions recorded organic growth of 15%. The company also raised its full-year 2026 outlook when it reported the quarterly results.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">The Life Science and Electronics divisions have contributed to the company&#8217;s recent growth, factors that HSBC considered as part of its assessment of the stock.  <\/p>\n<p>        Shares advance as broader equity markets decline          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Merck KGaA&#8217;s gain came during a session in which major U.S. equity indices moved lower. The S&amp;P 500 declined 0.6%, while the Nasdaq fell more than 1.0%.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">At \u20ac141.30, Merck KGaA shares remained below their 52-week high of \u20ac148.80.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">HSBC&#8217;s upgrade followed the company&#8217;s improved organic sales growth in the second quarter and its increased full-year guidance, while the brokerage also highlighted the stock&#8217;s recent performance relative to other companies in the sector.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Merck stock price  <\/p>\n","protected":false},"excerpt":{"rendered":"Woman in mask and gown holding a test tube \u00a9Adobe Stock Images Merck KGaA (NYSE:MRK) shares rose 1.7%&hellip;\n","protected":false},"author":2,"featured_media":115060,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20667],"tags":[9881,47113,36130,47110,47111,47112],"class_list":["post-115059","post","type-post","status-publish","format-standard","has-post-thumbnail","category-hsbc","tag-hsbc","tag-life-science-process-solutions","tag-merck","tag-merck-kgaa","tag-merck-kgaas","tag-the-life-science-and-electronics"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/117195736685771079","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/115059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=115059"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/115059\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/115060"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=115059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=115059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=115059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}